Methylmalonate Test

Your standard vitamin B12 number can look fine while your cells are starving for it. MMA (methylmalonic acid) catches that gap. It is the byproduct that piles up when B12-dependent machinery inside your mitochondria (the energy-producing parts of your cells) stops running cleanly, which is why elevated MMA shows up before classic deficiency symptoms appear.

Beyond B12 status, higher MMA has been linked in large adult cohorts to higher all-cause and cardiovascular mortality, worse cognition, frailty, and lower muscle mass. It is one of the few widely available markers that doubles as a functional read on B12 and a window into mitochondrial wear and tear.

What MMA Actually Reflects

MMA comes from the breakdown of certain amino acids (like valine and isoleucine), odd-chain fatty acids, and cholesterol side chains. Normally, an enzyme that depends on vitamin B12 converts this intermediate into a different molecule your cells can use for energy. When B12 is low, or when that enzyme is impaired by inherited disease or kidney issues, the intermediate gets shunted into MMA and spills into the blood and urine.

Because the enzyme needs B12 to function, MMA rises before serum B12 drops in many people. That makes it a functional marker, meaning it reflects whether your B12 is actually doing its job inside cells, not just whether B12 is present in your bloodstream.

Vitamin B12 Deficiency

This is the most established use of MMA testing. Serum B12 alone misses cases of functional deficiency because it measures the vitamin floating around, not how well your cells are using it. MMA and homocysteine catch deficiency earlier and more reliably, which is why expert reviews recommend combining markers rather than relying on serum B12 alone.

In one classic study, normal levels of both MMA and homocysteine essentially ruled out clinically meaningful B12 deficiency. Conversely, elevated MMA flagged people whose serum B12 looked acceptable but who still had functional shortfalls. Urinary MMA, expressed as a ratio to creatinine, has shown high specificity for B12 deficiency, particularly in people whose kidney function complicates blood-based interpretation.

Cardiovascular and All-Cause Mortality

In a large US cohort of 23,437 adults, higher MMA predicted higher all-cause and cardiovascular mortality even after accounting for B12 levels and kidney function. The risk climbed in steps across the population: people at or above 250 nmol/L had roughly 60 to 70 percent higher mortality risk than those below 120 nmol/L.

In a separate study of 7,662 patients with existing coronary heart disease, each one-standard-deviation rise in MMA was associated with roughly 20 to 30 percent higher risk of heart attack and death. Another analysis in 13,773 adults found MMA was independently linked to subclinical heart muscle injury and added predictive value on top of standard cardiac markers like high-sensitivity troponin.

What this means for you: a single elevated MMA does not diagnose heart disease, but a persistently high reading suggests a process worth investigating, especially alongside other cardiac markers.

Kidney Function and Chronic Kidney Disease

Your kidneys clear MMA, so reduced kidney function raises levels independent of B12. This is the single biggest confounder when reading MMA. In a study of 2,589 adults with chronic kidney disease, higher MMA was strongly linked to higher all-cause and cardiovascular mortality, while serum B12 showed no such link. A separate NHANES analysis found a positive association between serum MMA and chronic kidney disease itself.

If your kidney function is reduced, your baseline MMA will run higher than someone with normal filtration. That does not mean the number is meaningless, but it does mean interpretation has to happen alongside eGFR (a kidney filtration estimate).

Cognition, Frailty, and Sarcopenia

Higher MMA has been associated with worse cognitive performance in older adults across multiple cohorts, with one analysis of 2,762 participants linking elevated MMA to measurable cognitive decline, possibly through mitochondrial dysfunction (problems with the energy-producing parts of your cells).

In 10,414 adults with sarcopenia (age-related muscle loss), elevated MMA independently predicted both low muscle mass and higher mortality. In 119 older women newly diagnosed with breast cancer, higher serum MMA at diagnosis correlated significantly with clinical frailty. These findings position MMA as a marker of biological aging, not just B12 status.

Inherited Methylmalonic Acidemia

At the extreme end, rare inherited defects in the B12-dependent enzyme cause methylmalonic acidemia, where MMA accumulates at 10 to 100 times normal and causes metabolic crises, kidney disease, and severe neurological injury. This is diagnosed and monitored in childhood, often through newborn screening. For adults reading this article, the relevant takeaway is that MMA is the same molecule clinicians use to track these severe disorders, which is why mildly elevated levels are still worth taking seriously.

Reference Ranges

There is no single universal cutoff. The most-cited population reference data come from US NHANES, with age-specific upper limits derived from B12-replete adults with normal kidney function. Ranges shift with age, kidney function, and race or ethnicity, and your lab may use slightly different cutpoints. Use the table below as orientation, not as a target.

Source: NHANES-derived age-specific reference intervals (Mineva et al.), risk strata from Wang et al. (2020) on 23,437 US adults.

Age-specific upper limits in B12-replete adults with normal kidney function: about 254 nmol/L at 20 to 39 years, 293 nmol/L at 40 to 59 years, 281 nmol/L at 60 to 69 years, and 317 nmol/L at age 70 and above. Compare your results within the same lab over time, because methods and units vary between labs.

Why One Reading Is Not Enough

MMA is not a stable number. In one analysis, intra-individual variability in serum MMA averaged roughly 31 percent, with some patients showing variation up to 75 percent across measurements during the same hospital stay. Kidney function shifts, hydration, and recent dietary changes all nudge the number around.

That is exactly why trending matters more than a single result. Get a baseline now. If your level is borderline or elevated, retest in 3 to 6 months, especially if you have started B12 supplementation, changed your diet, or your kidney function has shifted. Once stable, an annual check is reasonable for proactive monitoring, and more often if you are managing CKD or actively correcting a deficiency.

When Results Can Be Misleading

A few factors can distort a single reading and lead to the wrong conclusion:

• Reduced kidney function: MMA accumulates when your kidneys cannot clear it. A high MMA in someone with low eGFR may reflect kidney function rather than true B12 insufficiency.
• Older age: MMA rises with age even in B12-replete adults with normal kidneys. Compare your result against age-appropriate ranges, not a generic adult cutoff.
• Race and ethnicity: Non-Hispanic White adults tend to run higher MMA than non-Hispanic Black adults in US population data. This is a population-level pattern, not a clinical adjustment, but it shows why single-cutoff thinking fails.
• Genetic variation: A common variant in the HIBCH gene shifts plasma MMA upward independent of B12 status, which can produce confusing readings in some people.

What an Abnormal Result Should Prompt

If your MMA is elevated, the next steps depend on the rest of your picture. The standard companion tests to order are serum B12, homocysteine, and a kidney function panel (creatinine, eGFR, cystatin C). Holotranscobalamin, which measures the biologically active fraction of B12, can add precision if available.

A pattern of high MMA plus high homocysteine plus low or low-normal B12 strongly suggests functional B12 deficiency that should be corrected. High MMA with normal homocysteine and reduced eGFR points more toward kidney clearance as the driver. High MMA with normal everything else, including kidney function, deserves a repeat measurement and a closer look at diet, gut absorption (think autoimmune gastritis, gastric bypass, long-term acid-suppressing medication), and B12 status across multiple markers. If MMA stays elevated after correction attempts, looping in a hematologist or internal medicine specialist makes sense.